These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38381080)

  • 1. Performance of Aldosterone-to-renin Ratio Before Washout of Antihypertensive Drugs in Screening of Primary Aldosteronism.
    Liu X; Hao S; Bian J; Lou Y; Zhang H; Wu H; Cai J; Ma W
    J Clin Endocrinol Metab; 2024 Nov; 109(12):e2302-e2308. PubMed ID: 38381080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
    Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a diagnostic model for pre-washout screening of primary aldosteronism.
    Wang Q; Dong H; Li HW; Zheng ZH; Liu YZ; Hua YH; Xiong YJ; Zhang HM; Song L; Zou YB; Jiang XJ
    J Endocrinol Invest; 2024 Oct; 47(10):2539-2550. PubMed ID: 38536656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests.
    Ruiz-Sánchez JG; Fernández Sánchez Á; Meneses D
    Endocrine; 2024 Aug; 85(2):906-915. PubMed ID: 38568364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
    Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
    J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension.
    Bioletto F; Lopez C; Bollati M; Arata S; Procopio M; Ponzetto F; Beccuti G; Mengozzi G; Ghigo E; Maccario M; Parasiliti-Caprino M
    Front Endocrinol (Lausanne); 2023; 14():1145186. PubMed ID: 37223051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
    Gallay BJ; Ahmad S; Xu L; Toivola B; Davidson RC
    Am J Kidney Dis; 2001 Apr; 37(4):699-705. PubMed ID: 11273868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
    Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Mulatero P; Rabbia F; Milan A; Paglieri C; Morello F; Chiandussi L; Veglio F
    Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for primary aldosteronism on and off interfering medications.
    Li X; Liang J; Hu J; Ma L; Yang J; Zhang A; Jing Y; Song Y; Yang Y; Feng Z; Du Z; Wang Y; Luo T; He W; Shu X; Yang S; Li Q;
    Endocrine; 2024 Jan; 83(1):178-187. PubMed ID: 37796417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
    Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
    PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.
    Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
    Endocrine; 2012 Aug; 42(1):182-9. PubMed ID: 22302679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary aldosteronism: Aldosterone/renin ratio cut-off points.
    Eugenio Russmann ML; Delfino L; Fierro F; Santoro S; Peréz M; Caruso G; Glikman P; Gauna A; Lupi S
    Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(6):361-367. PubMed ID: 30737120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs.
    Constantinescu G; Gruber S; Fuld S; Peitzsch M; Schulze M; Remde H; Kürzinger L; Yang J; Yen T; Williams TA; Müller L; Reincke M; Lenders JWM; Beuschlein F; Pamporaki C; Eisenhofer GF
    Hypertension; 2024 Oct; 81(10):2060-2071. PubMed ID: 39082132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.